Hydrogel-thickened microemulsion |
Carbomer 940, isopropyl myristate, Tween 80, propylene glycol, triethanolamine, menthol and water |
Transdermal administration |
New Zealand rabbits |
1.2 mg/kg (acute toxicity study), 0.06–0.54 mg/kg (long-term toxicity study) |
No obvious toxicities were observed in a series of toxicity tests, only mild reversible skin irritation signs were observed on the skin of animals |
[134] |
Kunming mice and beagle dogs |
0.03–0.27 mg/kg |
English guinea pigs |
0.006 mg/kg (3 × 3 cm2 skin) |
Microemulsion-based hydrogel |
Poloxamer 407, oleic acid, Gemseal 40, Labrasol, Tween 80, ethanol and water |
Transdermal administration |
Rabbits |
0.24 mg (3 × 3 cm2 skin) |
It afforded a better sustained release profile and strong permeability with low irritation when compared to microemulsions |
[135] |
Liposome hydrogel patch |
Egg lecithin, cholesterol, Viscomate NP-700, glycine aluminum, polyvinylpyrrolidone K-90, glycerin, tartaric acid and water |
Transdermal administration (after treated with microneedles) |
Male SD rats |
1.6, 10, 20, 40 mg/kg |
It provided a more stable and long-term release of triptolide compared with intragastric administration and had significant efficacy in CIA model |
[137] |
Solid lipid nanoparticles |
Glyceryl monostearate, soybean phospholipid, acetone, Poloxamer 188, Tween 80 and water |
Intragastrical administration |
Male SD rats |
0.45 mg/kg |
SLNs had a protective effect against triptolide-induced male reproductive toxicity due to lower concentrations in testicular tissue |
[140] |
Solid lipid nanoparticles |
Polyoxyl 40 hydrogenated castor oil, glyceryl behenate, diethylene glycol monoethyl ether, egg lecithin and water |
Intragastrical administration |
Male SD rats |
1.0 mg/kg |
SLNs alleviated the irritation in rat stomach tissues induced by triptolide, which could be attributed to reduced lipid peroxidation levels and inflammation of the stomach mucosa |
[110] |
Solid lipid nanoparticles |
Tristearin glyceride, Poloxamine 908, soybean lecithin and water |
Intragastrical administration |
Male Wistar rats and male Kunming mice |
0.2, 0.4 mg/kg |
SLNs increased the anti-inflammatory activity of triptolide and reduced triptolide-induced hepatotoxicity |
[141] |
Nanostructured lipid carriers |
Compritol 888 ATO, Capryol 90, Tween 80, Transcutol HP, soybean oil and water |
Transdermal administration |
Male SD rats |
9.3 mg/kg |
NLCs could effectively penetrate into skin for alleviating knee joint swelling and inhibiting inflammatory infiltration in RA rat model. |
[143] |
Lyotropic liquid crystals |
Phytantriol, carbitol, vitamin E acetate and water |
Transdermal administration |
SD rats |
0.08 mg/kg |
Triptolide-loaded cubic and hexagonal liquid crystals presented excellent anti-arthritic effects with no obvious toxicity |
[146] |
Polymeric micelles |
Methoxypolyethylene glycol–poly(D,L-lactic acid)-block copolymer |
Intravenous administration |
Kunming mice |
0.51–1.25 mg/kg |
Its acute and subacute toxicities were slighter than free triptolide owing to the sustained release characteristics and anti-lipid oxidative damage |
[85] |
Wistar rats |
0.1, 0.3 mg/kg |
Polymeric vesicles |
Poly-γ-glutamic acid-grafted l-phenylalanine ethylester copolymer |
Intravenous administration |
C57/B6 mice |
0.5 mg/kg |
It increased the survival rate of mice and reduced the damage of free TP on the liver, kidney, and spleen |
[147] |
Polymeric nanoparticles |
Poly-γ-glutamic acid-grafted di-tert-butyl L-aspartate hydrochloride |
Intravenous administration |
C57BL/6 mice |
0.15 mg/kg |
It could accumulate in the inflammatory joints of TNFα-Tg mice by EPR effect, with decreased death rate and toxicity at the liver and spleen induced by triptolide |
[149] |
Polymeric nanoparticles |
Galactosyl-dextran-retinal conjugates |
Intravenous administration |
Male Balb/c mice |
0.04 mg/kg |
It preferentially accumulated in the inflamed joints through active targeting in CIA mice, thus reducing systemic toxicity |
[150] |